-
EP2144998
European procedure
Extract from the Register of European Patents
EP About this file: EP2144998
| EP2144998 - METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.11.2017 Database last updated on 15.06.2024 | |
| Former | The patent has been granted Status updated on 02.12.2016 | ||
| Former | Grant of patent is intended Status updated on 23.11.2016 | Most recent event Tooltip | 10.11.2017 | No opposition filed within time limit | published on 13.12.2017 [2017/50] | Applicant(s) | For all designated states Takeda Vaccines, Inc. One Takeda Parkway Deerfield, IL 60015 / US | [2015/14] |
| Former [2012/49] | For all designated states Inviragen, Inc. 1613 Prospect Parkway, Suite 100 Fort Collins, CO 80525 / US | ||
| Former [2010/03] | For all designated states Inviragen, INC. 2619 Midpoint Drive, Suite A Fort Collins, Colorado 80525 / US | Inventor(s) | 01 /
STINCHCOMB, Dan T. 8409 County Road 3 Fort Collins, Colorado 80528 / US | 02 /
OSORIO, Jorge E. 560 Highway 78 South Mount Horeb, Wisconsin 53572 / US | 03 /
WIGGAN, O'Neil 1600 West Plum Street Fort Collins, Colorado 80521 / US | [2010/03] | Representative(s) | Bohmann, Armin K. Bohmann Anwaltssozietät Nymphenburger Straße 1 80335 München / DE | [2017/01] |
| Former [2010/03] | Bohmann, Armin K. Bohmann Anwaltssozietät Nymphenburger Strasse 1 80335 München / DE | Application number, filing date | 08826570.7 | 04.04.2008 | [2010/03] | WO2008US59472 | Priority number, date | US20070910579P | 06.04.2007 Original published format: US 910579 P | [2010/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009014774 | Date: | 29.01.2009 | Language: | EN | [2009/05] | Type: | A1 Application with search report | No.: | EP2144998 | Date: | 20.01.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.01.2009 takes the place of the publication of the European patent application. | [2010/03] | Type: | B1 Patent specification | No.: | EP2144998 | Date: | 04.01.2017 | Language: | EN | [2017/01] | Search report(s) | International search report - published on: | US | 29.01.2009 | (Supplementary) European search report - dispatched on: | EP | 06.10.2011 | Classification | IPC: | C12N7/04, C12N7/02, A61K39/12 | [2011/44] | CPC: |
A61K39/12 (EP,IL,KR,US);
C12N7/00 (EP,IL,KR,US);
A61K47/26 (IL,KR,US);
A61K47/36 (IL,KR,US);
A61K47/42 (IL,KR,US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/20 (EP);
C08L71/02 (EP,IL,KR,US);
A61K2039/5254 (EP,IL,US);
A61K2039/55555 (EP,IL,US);
A61K2039/70 (EP,IL,US);
C08G2650/58 (EP,IL,US);
C08L2203/02 (EP,IL,US);
C12N2710/10051 (EP,IL,US);
C12N2710/10061 (EP,IL,US);
C12N2710/24151 (EP,IL,US);
C12N2710/24161 (EP,IL,US);
C12N2760/16051 (EP,IL,US);
C12N2760/16061 (EP,IL,US);
C12N2760/18411 (EP,IL,US);
C12N2770/24134 (EP,IL,KR,US);
C12N2770/24151 (EP,IL,KR,US);
C12N2770/24161 (EP,IL,KR,US);
|
| Former IPC [2010/03] | C12N7/04 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2017/01] |
| Former [2010/03] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN FÜR LEBENDE ABGESCHWÄCHTE VIREN | [2010/03] | English: | METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES | [2010/03] | French: | PROCEDES ET COMPOSITIONS POUR VIRUS VIVANTS ATTENUES | [2010/03] | Entry into regional phase | 06.11.2009 | National basic fee paid | 06.11.2009 | Search fee paid | 06.11.2009 | Designation fee(s) paid | 06.11.2009 | Examination fee paid | Examination procedure | 06.11.2009 | Examination requested [2010/03] | 04.05.2012 | Amendment by applicant (claims and/or description) | 15.06.2012 | Despatch of a communication from the examining division (Time limit: M04) | 25.10.2012 | Reply to a communication from the examining division | 14.04.2014 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2014 | Reply to a communication from the examining division | 02.02.2015 | Communication of intention to grant the patent | 12.06.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.07.2015 | Communication of intention to grant the patent | 26.11.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 17.12.2015 | Observations by third parties | 21.12.2015 | Communication of intention to grant the patent | 02.05.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 12.07.2016 | Communication of intention to grant the patent | 22.11.2016 | Fee for grant paid | 22.11.2016 | Fee for publishing/printing paid | 22.11.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | EP15001669.9 / EP2940129 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.06.2012 | Opposition(s) | 05.10.2017 | No opposition filed within time limit [2017/50] | Fees paid | Renewal fee | 01.02.2010 | Renewal fee patent year 03 | 06.04.2011 | Renewal fee patent year 04 | 21.03.2012 | Renewal fee patent year 05 | 12.04.2013 | Renewal fee patent year 06 | 25.03.2014 | Renewal fee patent year 07 | 10.04.2015 | Renewal fee patent year 08 | 11.04.2016 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO03086443 (MEDIMMUNE VACCINES INC [US], et al) [X] 11-15 * example 1 * * page 9, paragraph 23 * [I] 1-10; | [XI]WO03087327 (MEDIMMUNE VACCINES INC [US], et al) [X] 11-15 * examples 1, 2 * * page 34, paragraph 116 *[I] 1-10 | International search | [X]US2005255121 (CAMPBELL ROBERT L [US], et al); | [A]US2005276785 (GROETZBACH GEORG [DE], et al) | Examination | - FUSSNEGGER B, "Poloxamers (2)", BASF EXACT, (200004), no. 4, pages 7 - 9 | by applicant | WO03086443 | WO03087327 |